Article Details

Clovis Oncology (NASDAQ:CLVS) Given Consensus Recommendation of "Hold" by Analysts

Retrieved on: 2021-01-02 09:31:53

Tags for this article:

Click the tags to see associated articles and topics

Clovis Oncology (NASDAQ:CLVS) Given Consensus Recommendation of "Hold" by Analysts. View article details on hiswai:

Excerpt

50.26% of the stock is owned by hedge funds and other institutional investors. About Clovis Oncology. Clovis Oncology, Inc, a biopharmaceutical ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo